Home Drug Codes C Codes C9304 · HYMPAVZI
Updated July 1st, 2026

HYMPAVZI C Code: C9304

Injection, marstacimab-hncq, 0.5 mg

Login to unlock all benchmarks
Medicare Payment Limit ?
Not published
CMS publishes none for Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
No current ASP
Not available for Q3 2026
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
1
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, marstacimab-hncq, 0.5 mg
HCPCS Added Date April 1, 2025
Manufacturer Pfizer
Route of Administration Subcutaneous
Generic Status HCPCS Discontinued
Dosage Type Single-Dose
Dosage Form Injection, Solution

About HYMPAVZI

Hympavzi is a medication aligned to the HCPCS C Code: C9304 for billing, pricing, and reimbursement purposes in the United States. This Hematology medication is administered via the subcutaneous route and manufactured by Pfizer.

Manufacturers, reach out to us to add more information.

NDC Code Information

1 NDC package is crosswalked to C9304. Package detail is available to logged-in subscribers.

Login to view 1 NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

HYMPAVZI CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96372 Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular
Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

HYMPAVZI Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Hemophilia A (congenital factor VIII deficiency) Hemophilia B (congenital factor IX deficiency)

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there a manufacturer-published HYMPAVZI billing and coding guide?
Our team has not identified a manufacturer-published source of billing and coding information for HYMPAVZI.
What are the available HYMPAVZI patient assistance programs?
Our team has not identified a manufacturer-published source of patient assistance information for HYMPAVZI.
Where can I find HYMPAVZI prescribing information?
HYMPAVZI prescribing information can be found at the link below. Visit Here →
Where can I find HYMPAVZI side effect information?
Side effect information for HYMPAVZI can be found at the following source.
Does billing HYMPAVZI require JZ/JW wastage modifiers?
CMS does not include HYMPAVZI (C9304) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing C9304. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.